Browse by author
Lookup NU author(s): Dr Sasha Gartside
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The 5-HT receptor agonists, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) produced dose-dependent increases in plasma adrenocorticotropin (ACTH) in the male rat by activation of 5-HT1A and 5-HT2 receptors respectively. The ACTH response to DOI was enhanced by repeated administration of electroconvulsive shock (five over 10 days) but abolished by the tricyclic antidepressant, amitriptyline (20 mg/kg for 14 days). In contrast 21 days lithium treatment failed to alter DOI-induced ACTH release. Neither repeated electroconvulsive shock, nor amitriptyline, nor lithium altered the ACTH response to 8-OH-DPAT. These data are consistent with results from ligand binding and behavioural studies which suggest that the sensitivity of brain 5-HT2 receptors is increased by repeated electroconvulsive shock but attenuated by tricyclic antidepressant treatment. In contrast, our data suggest that the antidepressant treatments studied do not alter the sensitivity of the 5-HT1A receptors involved in ACTH release.
Author(s): Gartside SE, Ellis PM, Sharp T, Cowen PJ
Publication type: Article
Publication status: Published
Journal: European Journal of Pharmacology
Print publication date: 06/10/1992
ISSN (print): 0014-2999
ISSN (electronic): 1879-0712
Notes: 0014-2999 (Print)
Altmetrics provided by Altmetric